Summary & Overview
HCPCS G9234: Total Knee Replacement Measures Group Reporting
HCPCS Level II code G9234 denotes an intent-to-report entry for the total knee replacement measures group, signaling that a provider plans to submit quality measures associated with total knee arthroplasty. Nationally, codes like G9234 matter because they support benchmarking, quality measurement, and payer reporting workflows tied to a high-volume surgical episode with significant cost and quality implications.
Key payers included in this overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise explanation of what the code represents, the clinical and service context for total knee replacement reporting, and the types of benchmarks and policy topics typically associated with measures-group reporting: measure alignment, payer reporting requirements, and clinical measure relevance for postoperative outcomes and care coordination.
This publication provides context on where G9234 fits in billing and reporting workflows, highlights the national importance of standardized measures for total knee replacement, and identifies gaps where more payer-specific reporting detail or modifiers would normally be required. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code G9234 is described as I intend to report the total knee replacement measures group. This code represents an intent-to-report marker for quality and performance reporting related to total knee replacement procedures.
-
Service type: Quality reporting / measures group reporting related to total knee replacement
-
Typical site of service: Hospital inpatient or ambulatory surgical settings where total knee replacement procedures and associated quality reporting occur
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with advanced tricompartmental osteoarthritis of the knee presents for evaluation after months of progressive pain, reduced ambulation, and failure of conservative therapy (physical therapy, intra-articular steroid injections, and NSAIDs). Imaging confirms end-stage degenerative changes with joint space loss and osteophyte formation. The orthopedic surgeon schedules the patient for total knee arthroplasty as part of the total knee replacement measures group to track perioperative quality metrics and outcomes.
The clinical workflow includes preoperative assessment (medical clearance, medication reconciliation, optimization of comorbidities such as diabetes and anticoagulation management), informed consent, perioperative antibiotic prophylaxis, implant selection and documentation, the operative procedure (primary total knee arthroplasty), immediate postoperative monitoring in the PACU, inpatient postoperative care focusing on pain control and early mobilization, physical therapy initiation, discharge planning (home or skilled nursing), and 30-day to 90-day follow-up for functional assessment and complication surveillance. Quality reporting captures measures such as surgical site infection prevention, venous thromboembolism prophylaxis, implant registry submission, and patient-reported outcomes associated with the total knee replacement measures group.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure |